2m 2m 2m 2m 2m 2m 2m
EVOLUS (EOLS)
NASDAQ
$5.98-$0.19 (-3.08%)
Price as of Jun 03, 2026 6:15 PM EDT- $432.0MMarket Cap
- -38.05%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
EVOLUS (EOLS)
$5.98-$0.19 (-3.08%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 295.0M +10.77% | 266.3M +31.76% | 202.1M +35.98% | 148.6M +49.10% | |
Cost of Revenue | 100.1M +19.17% | 84.0M +36.41% | 61.6M +10.15% | 55.9M +28.38% | |
Gross Profit | 197.1M +8.12% | 182.3M +29.73% | 140.5M +51.54% | 92.7M +65.18% | |
Sales and Marketing Expense | 220.8M +11.49% | 198.0M +20.06% | 164.9M +16.29% | 141.8M +26.57% | |
Research and Development Expense | -9.6M +4.40% | -9.2M +39.90% | -6.6M -2.76% | -6.7M +226.65% | |
Depreciation and Amortization Expense | 7.5M +41.70% | 5.3M +3.20% | 5.1M +37.91% | 3.7M -33.80% | |
Total Operating Expenses | 229.8M +6.02% | 216.7M -13.77% | 251.3M +17.47% | 213.9M +48.49% | |
Operating Profit | -32.7M -5.08% | -34.4M -30.11% | -49.2M -24.64% | -65.3M +47.12% | |
Interest Income | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Expense | N/A N/A | N/A N/A | -13.8M +52.05% | -9.1M N/A | |
Interest Income and Expense and Net | 0 N/A | 0 +100.00% | -13.8M +52.05% | -9.1M N/A | |
Total Nonoperating Income and Expense | -539,000 -524.41% | 127,000 -81.75% | 696,000 +7,833.33% | -9,000 -99.36% | |
Income before Taxes | -51.0M +2.43% | -49.8M -19.11% | -61.5M -17.23% | -74.3M +58.91% | |
Income Taxes | 677,000 +1.96% | 664,000 +277.27% | 176,000 +85.26% | 95,000 +126.19% | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -51.6M +2.42% | -50.4M -18.26% | -61.7M -17.10% | -74.4M +58.97% | |
Net Income from Continuing Operations Applicable to Common | -51.0M +2.43% | -49.8M -19.11% | -61.5M -17.23% | -74.3M +58.91% | |
Basic EPS and Net Income | -0.80 -1.23% | -0.81 -25.00% | -1.08 -18.80% | -1.33 +41.49% | |
Diluted EPS and Net Income | -0.80 -1.23% | -0.81 -25.00% | -1.08 -18.80% | -1.33 +41.49% | |
Basic Weighted Average Shares | 64.5M +3.95% | 62.0M +8.96% | 56.9M +1.52% | 56.1M +12.64% | |
Diluted Weighted Average Shares | 64.5M +3.95% | 62.0M +8.96% | 56.9M +1.52% | 56.1M +12.64% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 53.8M -38.10% | 87.0M +38.37% | 62.8M +16.53% | 53.9M -63.13% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 53.8M -38.10% | 87.0M +38.37% | 62.8M +16.53% | 53.9M -63.13% | |
Total Current Assets | 142.9M -5.57% | 151.3M +34.62% | 112.4M +11.53% | 100.8M -43.62% | |
Accumulated Depreciation | 4.8M +35.08% | 3.5M N/A | N/A N/A | N/A N/A | |
Property and Plant and Equipment and Net | 5.4M +66.70% | 3.2M +54.38% | 2.1M -20.22% | 2.6M +90.81% | |
Total Long-Term Assets | 1.2M +39.74% | 858,000 +109.78% | 409,000 -85.46% | 2.8M +1.99% | |
Total Assets | 225.9M -2.88% | 232.6M +23.05% | 189.0M +6.19% | 178.0M -30.88% | |
Income Taxes Payable | 28,000 +366.67% | 6,000 -77.78% | 27,000 +22.73% | 22,000 -45.00% | |
Total Short-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Current Liabilities | 75.3M +19.61% | 63.0M +30.38% | 48.3M +3.83% | 46.5M -19.34% | |
Total Long-Term Debt | 146.1M +20.24% | 121.5M +0.95% | 120.4M +67.45% | 71.9M +0.92% | |
Total Long-Term Liabilities | 6.4M -5.02% | 6.8M +39.12% | 4.9M +283.60% | 1.3M -45.72% | |
Total Liabilities | 249.0M +9.66% | 227.0M +8.28% | 209.7M +31.48% | 159.5M -9.18% | |
Retained Earnings | -661.0M +8.47% | -609.4M +9.02% | -559.0M +12.40% | -497.3M +17.60% | |
Total Stockholders Equity | -23.1M -518.44% | 5.5M +126.69% | -20.7M -211.84% | 18.5M -77.41% | |
Total Shares Outstanding | 65.0M +2.38% | 63.5M +9.82% | 57.8M +2.77% | 56.3M +1.23% | |
Cash Flow | |||||
Cash from Operating Activities | -42.3M +134.82% | -18.0M -47.07% | -34.0M -59.95% | -84.9M +154.32% | |
Capital Expenditures | 3.4M +133.76% | 1.5M +211.21% | 473,000 -70.77% | 1.6M +311.70% | |
Cash from Investing Activities | -8.5M +75.24% | -4.8M +196.44% | -1.6M -44.64% | -2.9M -172.93% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 17.3M -63.43% | 47.4M +6.21% | 44.6M +1,176.72% | -4.1M -105.68% | |
Financials Ratio | |||||
Gross Margin | 66.07% -3.49% | 68.46% -1.54% | 69.54% +11.45% | 62.40% +10.78% | |
Operating Margin | -11.07% -14.31% | -12.92% -46.95% | -24.36% -44.58% | -43.96% -1.33% | |
Return on Assets | -22.53% -5.82% | -23.92% -28.85% | -33.62% -1.63% | -34.18% +70.31% | |
Return on Equity | 587.36% -11.66% | 664.86% -88.20% | 5,633.33% +3,899.43% | -148.27% -85.88% | |
Revenue Growth | 10.77% -66.09% | 31.76% -11.71% | 35.98% -26.73% | 49.10% -35.63% | |
Current Ratio | 1.90 -21.05% | 2.40 +3.26% | 2.33 +7.41% | 2.17 -30.10% | |
Cash Ratio | 0.71 -48.24% | 1.38 +6.14% | 1.30 +12.23% | 1.16 -54.29% | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow